PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Występowanie farmaceutyków w środowisku wodnym oraz możliwości ich usuwania

Autorzy
Identyfikatory
Warianty tytułu
EN
Pharmaceuticals in water environment - problems and removal methods
Języki publikacji
PL
Abstrakty
PL
Badania potwierdziły obecność leków w ściekach surowych i oczyszczonych na terenie Polski. W rzekach na terenie Polski stwierdzono obecność estrogenów, leków z grupy NLPZ: diklofenaku w Warcie w stężeniu 0,38 jj.g/1, naproksenu w Wiśle - 0,11-0,3 Hg/1 czy kwasu acetylosalicylowego w Odrze w stężeniu 0,73 |ig/l. Ponadto stwierdzono obecność leków w wodach pitnych (np. diklofenaku - 5 ng/1). Obecność farmaceutyków w wodach pitnych może być zagrożeniem dla zdrowia człowieka. By wyeliminować zanieczyszczenia spowodowane lekami, należy zastosować nowoczesne metody oczyszczania ścieków. Adsorpcja na węglach aktywnych, fotodegradacja i techniki membranowe skutecznie zmniejszają stężenie większości leków w ściekach oczyszczonych i wodach pitnych.
EN
The research results confirmed the presence of pharmaceuticals in raw wastewater and wastewater treated in wastewater treatment plants located in Poland. On the area of Poland the presence of estrogens, pharmaceuticals belonging to the group of NSAIDs; diclofenac in the concentration of 0,38 fjg/1 was detected in the Warta river, naproxen in the concentration of 0,11-0,3 pg/1 in the Wisla river, and acetylsalicylic acid in the concentration of 0,73 jj.g/1 was detected in Odra river. What is more, the presence of pharmaceuticals in drinking water, i.e. diclofenac in the concentration of 5 ng/1 was detected. The presence of pharmaceuticals in drinking water can pose significant threats to human health. Removal of the contamination caused by pharmaceuticals requires advanced wastewater treatment methods. Activated carbons, photodegradation and membrane techniques are efficient in reducing the concentration of most pharmaceuticals in treated wastewater and drinking water.
Czasopismo
Rocznik
Tom
Strony
20--25
Opis fizyczny
Bibliogr. 33 poz., rys., tab.
Twórcy
autor
  • Politechnika Częstochowska, Instytut Inżynierii Środowiska
Bibliografia
  • [1] http://www.rynekaptek.pl/dystrybucja/ ims-rynek-lekow-otc-zyska-na- znaczeniu, 4919.html
  • [2] http://www.egospodarka. pl/70706,Branza-farmaceutyczna-a-p0l- ska- gospodarka,1,39,l.html
  • [3] Sosnowska K., Grochowiak- Styszko K., Golas J., Leki w środowisku- źródła, przemiany, zagrożenia, Krakowska Konferencja Młodych Uczonych, 2009.
  • [4] Zhang Y., Geissen S., Gal C., Carbamaze- pine and diclofenac. Removal In wastewater treatment plants and occurrence In water Dobies, Chemosphere, 73 (2008), 1151-1161.
  • [5] Wasik-Kot A., Dębska J., Namiesnik, Pozostałości środków farmaceutycznych w środowisku- przemiany, stężenia, oznaczenia, Chemia i Inżynieria Ekologiczna, 10 (2003), 723-750.
  • [6] Migowska N., Caban M., Stepanowski P., Simultaneous analysis of non-steroidal anti- inflammatory and estrogenic hormones In water and wastewater samples using gas chromatography - mass spectrometry and gas chromatography with electron capture detection, Science of the Total Environment, 441 (2012), 77-88.
  • [7] Nikolaou A., Meric S .,Fatta D., Occurrence patterns of pharmaceuticals in water and wastewater envionments, Anal. Bio- anal Chem, 387 (2007), 1225-1234.
  • [8] Cunningham L.V, Special Characteristic of Pharmaceuticals Related to Environmental Fate, Pharmaceiticals in Environ- met, (2008), 23-34.
  • [9] Salgado R., Marques R., Noronha J.P., Assessing the removal of pharmaceuticals and personal care products in full- -scale activated sludge plant, Environ. Sci. Pollut. Res., 19 (2012), 1818-1827.
  • [10] Ziylan A., Ince N.H., The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water; Treatability by conventional and non-conventional process. Journal of Hazardous Materials, 187 (2011), 24-36.
  • [11] Buttiglieri G., Knepper T.P., Removal of Emerging Contaminants in Wastewater Treatment; Conventional Activated Sludge Treatment, Hdb Env. Chem., 5 (2008), 1-35-
  • [12] Kasprzyk-Hordern B., Dąbrowska A., Vieno N., Kronberg L., Nawrocki J., Occurrence of Acidic Pharmaceuticals in the Warta River in Poland, Chem., Anal (Warsaw), 52 (2007), 289-303.
  • [13] Baranowska I., Kowalski B., A Rapid UHPLC Method for the Simultaneous Determination of Drugs from Different Therapeutic Groups in Surface Water and Wastewater, Bull Environ Contam Toxicol, 89 (2012), 8-14.
  • [14] Daneshvar A., Svanfelt J., Kronberg L., Winter accumulation of acidic pharmaceuticals in a Swedish river, Environ Sci Pollut Res,17 (2010), 908-916.
  • [15] Schmitt-Jansen M., Bartels P., Adler N., Altenburger R., Phytotoxicity assessment of diclofenac and its phototransformation products, Anal Bioanal Chem, 387 (2007), 1389-1396.
  • [16] Zgoła-Grześkowiak A., Application of DLLME to Isolation and Concentration of Non-Steroidal Anti-Inflammatory Drugs in Environmental Water Samples, Chro- matographia, 72 (2010), 671-678.
  • [17] Baranowska I., Kowalski B., The Development of SPE Procedures and an UHPLC Method
  • [18] for the Simultaneous Determination of Ten Drugs in Water Samples, Water Air Soil Pollut, 211 (2010), 417-425.
  • [19] Dudziak M., Luks-Betlej K., Ocena obecności estrogenów - steroidowych hormonów płciowych w wybranych wodach rzecznych w Polsce, Ochrona Środowiska, 26 (2004), 21-24.
  • [20] Lehnberg K., Kovalova L., Kazner Ch., Wintgens T., Schettgen T., Melin T., Hollender J. and Dott W., Removal of Selected Organie Micropollutants from WWTP Effluent with Powdered Activated Carbon and Retention by Nanofiltration, Atmospheric and Biological Environmental Monitoring, 2009, 161-178.
  • [21] Grover D.P., Zouh J.L., Frickers P.E., Re- adman J.W., Improved removal of estrogenic and pharmaceutical compounds in sewage effluent by full scale granular activated carbon: Impact on receiving river water, Journal of Hazardous Materials, 185 (2011), 1005-1011.
  • [22] Melillo M., Phillips G.J., Davies J.G., Lloyd A.W., Tennison S.R., The effect of protein binding on ibuprofen adsorption to activated carbons, Carbon, 42 (2004), 565-571-
  • [23] Cuerda-Correa E.M., Dominguez-Vargas J.R., Olivares-Marin F.J., On the use of carbon black as potential low-cost adsorbents for the removal of non-steroidal anti-inflammatory drugs from river waters, Journal of Hazardous Materials, 177 (2010), 1046-1053.
  • [24] Aguinaco A., Beltran F.J., Garcia-Araya J.F., Oropesa A., Photocatalytic ozonation to remove the pharmaceutical diclofenac from water: Influence of variables, Chemical Engineering Journal, 189-190 (2012), 275-282.
  • [25] Adamek E., Jakubczyk J., Baran W., Makowski A., Lipska I., Fotodegrada- cja wybranych leków przeciwzapalnych w środowisku wodnym, Proceedings of ECOpole, 5 (2011), 149-153-
  • [26] Klavarioti M., Mantzavinos D., Kassinos D., Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes, Environmental International, 35 (2009), 402-417.
  • [27] Ziylan A., Ince N.H., The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: Treatability by conventional and non-conventional processes, Journal of Hazardous Materials, 187 (2011), 24-36.
  • [28] Malato S., Removal of Emerging Contaminants In Waste-water Treatment: Removal by Photo-catalytic Processes, Hdb Env Chem., 5 (2008), 177-197.
  • [29] Bo L., Urase T., Wang X., Biodégradation of trace pharmaceutical substances in wastewater by a membrane bioreak- tor, Front Environ Sci. Engin. China, 3 (2009), 236-240.
  • [30] Jacobs L.E., Fimmen R.L., Chin Y.P., Mash H.E., Weavers L.K., Fulvic acid mediated photolysis of ibuprofen in water, Water Research, 45 (2011), 4449-4458.
  • [31] Hata T., Kawai S., Okamura H., Nishida T., Removal of diclofenac and mefenamic acid by the white rot fungus Phanerocha- ete sordida YK-624 and identification of their metabolites after fungal transformation, Biodégradation, 21 (2010), 681-689.
  • [32] Antunes M., Esteves V.I., Guégan R., Crespo J.S, Fernandes A.N., Giovanela M., Removal of diclofenac sodium from aqueous solution by Isabel grape bagasse, Chemical Engineering Journal, 192 (2012), 114-121.
  • [33] COM 875 report from Commission of European Parliament and the Council on the outcome of the review of Annex of Directive 2000/60/EC of the European Parliament and of the Council on priority substances In the field of water policy Brussels 31.01.2012, 2011.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BPC2-0026-0002
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.